SELECTIVE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS

Spoj strukturne formule I, ili njegova farmaceutski prihvatljiva sol, solvat, hidrat ili stereoizomer, naznačen time što: svaki od R1 i R2 je neovisno: metil ili etil. Patent sadrži još 9 patentnih zahtjeva. The present invention is directed to a novel compound, its composition and use of a compound...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MARIA DELORES MARTIN-ORTEGA FINGER, RAFAEL FERRITTO-CRESPO
Format:	Patent
Sprache:	hrv ; eng
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Spoj strukturne formule I, ili njegova farmaceutski prihvatljiva sol, solvat, hidrat ili stereoizomer, naznačen time što: svaki od R1 i R2 je neovisno: metil ili etil. Patent sadrži još 9 patentnih zahtjeva. The present invention is directed to a novel compound, its composition and use of a compound having a structural formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomers thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases